SAO PAULO (Reuters) – Brazilian health regulator Anvisa approved on Thursday the beginning of clinical trials in the country for a new COVID vaccine developed by Canada’s Medicago R&D Inc and GlaxoSmithKline PLC, Anvisa said in a statement. Anvisa said the companies were authorized to conduct phase 3 trials in the country. The companies are
A 2.4-mg weekly injection of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide led to a clinically meaningful 5% loss in weight for roughly two thirds of patients with both overweight/obesity and type 2 diabetes, researchers report. These findings from the Semaglutide Treatment Effect in People With Obesity 2 (STEP 2) trial, one of four phase
Traditionally, National Hispanic Heritage Month is marked from September 15th to October 15th and honors the cultures and contributions of Hispanic and Latino Americans. In recognition of this culturally significant month, learn more about the Pfizer Latino colleagues who are making a difference in the fight against COVID-19. At Pfizer, we believe that developing a
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok